COMPANY 

INSIGHT

Sponsored by

qmedics

We manufacture state-of-the-art products Environmental-friendly and can flexibly adjust our production capacities to your order situation.

The following are a few of the key medical applications where ElectroCraft motors empower medical motion control.

Company History 

QMEDICS is a young Swiss-based medical device manufacturer founded in 2008. Our long year experience in the medical device industry has made us very flexible and highly capable of finding the optimum solution for every customer specific need. We were until 2016 a pure contracted manufacturing company – since then we became a PLM (private label) manufacturing of our own Peripheral product portfolio.


This was a company strategy change that resulted in a new management, new and more R&D engineers, the start of direct customer contact, a sales and marketing strategy in short, a start up in an experienced environment this combination is just ideal.

Our Vision 

At QMEDICS We work hard every day. To make sure that our guiding principle strive for state-of-the-art products every day, is reflecting in everything we do.

As a medical device company, we embrace the changing healthcare environment and seek to identify and explore opportunities as they emerge. With the best patient care always in mind, we insist on innovation, highest quality and to put the patient in the middle of our research not economics, profit or politics.

Contracted Manufacturing

Qmedics is a trusted partner with in-house stent and balloon development, manufacturing and logistical service. We supply custom tailored products, solutions and technologies. We produce already for big players in PTA and PTCA medical world.


Our Expertise are the following technologies:

Blow molding

Plastic wielding

Stent loading &

Deployment technologies

Stent & Balloon delivery System & Catheters

Laser cutting and wielding

Surface finishing

Big advantage of Qmedics: We do it all inhouse, no external Processes

R&D

V&V Testing

Quality Compliance

Regulatory Compliance

Manufacturing

Final Packaging

Sterilization

Shipping

Our Portfolio

Pull Stent type


To provide perfect balance between compression resistance and longitudinal conformability, in difficult to cross and moderate to severe calcification lesions


Flex Stent Type


The FLEX property is designed to provide a perfect balance between radial compression resistance and flexion deformation, in complex to cross and moderate calcification lesions

With the tree variants: 4,5,6 Fr compatible introducer.

With the full portfolio of PTA balloons

EXIST 6F

FALCOR 5F

DRACO 4F

Manatee

Naga

Nova

NEWS:

NEW PRODUCT added to our Portfolio

31. July 2019

Our investors made it possible to expand our product portfolio with “Easyx“ a liquid Embolic that provides another treatment option for peripheral physicians - the start in Qmedics embolization portfolio, Qmedics embolization pipeline: occlusion balloon and an embolization plug


The EASYX™ Liquid Embolic is a new injectable, precipitating polymeric agent for the obliteration of vascular spaces through direct puncture or catheter access performed under X-ray guidance. The embolic liquid is iodinized Polyvinyl Alcohol (PVA) Polymer ether. Iodine groups are covalently grafted to the PVA polymer backbone, whereby a stable nondegradable polymer with the desired features is created. The resulting polymer is dissolved in Dimethyl Sulfoxide (DMSO).


EASYX™ is CE-marked since December 2016 for the use in peripheral vasculature. The safety and efficacy of EASYX™ embolization liquid for the percutaneous treatment of vascular lesions, i.e. embolization of varicocele, type II endoleaks, portal vein before surgery, active peripheral bleeding or angiomyolipoma (AML) was proven in a clinical trial EASYX-1.

EASYX-1: A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate Indications. Publication is planned very soon.

Second clinical trial for the extention of the EASYX indications:


Prospective, Multicenter, Multinational Study to Assess the Safety and Performance of the Easyx Liquid Embolic in Intracranial Interventions IDEALE Study.
This is a Prospective Study to Assess the Safety and Performance of the Easyx Liquid Embolic in Intracranial Interventions.

Applied Harmonics:

These are just a sampling of the applications that ElectroCraft provides motion control solutions for in the medical market, and only a hint at future innovation. As a custom motor and motion control solution provider, ElectroCraft is the ideal partner for your medical equipment requirements.

Go to article: Home | The Surgical Robot RevolutionGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: In This IssueGo to article: Telemed Company InsightGo to article: TelemedGo to article: ContentsGo to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: The magic touch: bringing sensory feedback to brain-controlled prostheticsGo to article: Picosun Company Insight Go to article: PicosunGo to article: Medicoat Go to article: The high-tech hunt for new biomarkersGo to article: MPS Microsystems Company InsightGo to article: MPS MicrosystemsGo to article: OmnitronGo to article: Making robotic surgery safe: why training is key to avoiding tragedy Go to article: BioInteractions Company Insight Go to article: BioInteractions Go to article: XavitechGo to article: Virtual pain relief: could VR start a rehab revolution?Go to article: Industrial Indexing Systems Company Insight Go to article: Industrial Indexing SystemsGo to article: Low battery: finding alternative ways to power medical devicesGo to article: Key Plastics Company Insight Go to article: Key PlasticsGo to article: NSFGo to article: Hidden figures: lifting the lid on medical device failure reportingGo to article: Protomatic Medical Company InsightGo to article: Protomatic MedicalGo to article: Watlow Plasmatech Company Insight Go to article: WatlowGo to article: Making sustainable medical devices: five top tipsGo to article: ARPA Company InsightGo to article: ARPAGo to article: ICU techGo to article: Predicting cardiac risk: new approaches in AI and blood testingGo to article: Under the skin: the medical device industry and the dark webGo to article: Sandvik Company InsightGo to article: Sandvik Go to article: Q&A: LifeBank on the challenge of getting blood from A to B in Nigeria Go to article: Cap Biomaterials Company Insight Go to article: Cap BiomaterialsGo to article: Debate: Can Alexa be trusted with our health questions?Go to article: AtoZ-CRO Company InsightGo to article: AtoZ-CRO Go to article: Pleora TechnologiesGo to article: Maraca InternationalGo to article: Europlasma Company Insight Go to article: EuroplasmaGo to article: Combinostics Company Insight Go to article: EventsGo to article: Euroquartz Company InsightGo to article: EuroquartzGo to article: Next issueGo to article: mdi ConsultantsGo to article: Ginolis Company InsightGo to article: GinolisGo to article: Sab BroeckskesGo to article: Qmedics Company Insight Go to article: Qmedics